A detailed history of Brevan Howard Capital Management LP transactions in Vericel Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 10,957 shares of VCEL stock, worth $436,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,957
Holding current value
$436,746
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$29.84 - $41.74 $326,956 - $457,345
10,957 New
10,957 $344,000
Q4 2024

Feb 14, 2025

BUY
$40.05 - $59.11 $212,264 - $313,283
5,300 New
5,300 $291,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.